Showing 101 - 120 results of 214 for search '"statin"', query time: 0.05s Refine Results
  1. 101

    Rosuvastatin-Induced Oral Ulcer: A Case Report and Review of Literature by Metab Algeffari, Mansour Alsharidah

    Published 2022-01-01
    “…The benefits of prescribing statins are well published in the treatment of hypercholesterolemia. …”
    Get full text
    Article
  2. 102

    Lovastatin Decreases the Expression of CD133 and Influences the Differentiation Potential of Human Embryonic Stem Cells by Ade Kallas-Kivi, Annika Trei, Toivo Maimets

    Published 2016-01-01
    “…The lipophilic statin lovastatin decreases cholesterol synthesis and is a safe and effective treatment for the prevention of cardiovascular diseases. …”
    Get full text
    Article
  3. 103

    Severe Rhabdomyolysis Associated with Simvastatin and Role of Ciprofloxacin and Amlodipine Coadministration by Nicolas De Schryver, Xavier Wittebole, Peter Van den Bergh, Vincent Haufroid, Eric Goffin, Philippe Hantson

    Published 2015-01-01
    “…Simvastatin is among the most commonly used prescription medications for cholesterol reduction and the most common statin-related adverse drug reaction is skeletal muscle toxicity. …”
    Get full text
    Article
  4. 104

    Diabetes and Stroke Prevention: A Review by Jonathan Hewitt, Luis Castilla Guerra, María del Carmen Fernández-Moreno, Cristina Sierra

    Published 2012-01-01
    “…Lipids should be treated with a statin whatever the starting cholesterol. Antiplatelet treatment is also essential but there are no specific recommendations for the diabetic person. …”
    Get full text
    Article
  5. 105

    Nitric Oxide in Cerebral Vasospasm: Theories, Measurement, and Treatment by Michael Siuta, Scott L. Zuckerman, J. Mocco

    Published 2013-01-01
    “…Recent evidence indicates that targeting NOS dysfunction, for example, through erythropoietin or statin administration, also shows promise at preventing vasospasm and neurotoxicity. …”
    Get full text
    Article
  6. 106

    Creating National Weights for a Patient-level Longitudinal Database by Onur Baser, Li Wang, Jon Maguire

    Published 2016-03-01
    “…The annual number of statin users were predicted as 6 709 438 using weighted MEPS data. …”
    Get full text
    Article
  7. 107
  8. 108

    The Role of Angiotensin Antagonism in Coronary Plaque Regression: Insights from the Glagovian Model by Abdul H. Alkatiri, Doni Firman, Amir A. Alkatiri, Paskalis I. Suryajaya, Albert Sudharsono

    Published 2021-01-01
    “…Significant coronary atheromatous plaque regression has been previously demonstrated in various studies using statin agents. Similar results have been reported in different studies using angiotensin inhibitor agents, notably ARB agents. …”
    Get full text
    Article
  9. 109

    Minimally Invasive Periodontology: A Treatment Philosophy and Suggested Approach by Ethan Ng, John Rong Hao Tay, Marianne Meng Ann Ong

    Published 2021-01-01
    “…This may involve repeated rounds of nonsurgical periodontal therapy, and adjuncts such as locally delivered statin gels and subantimicrobial-dose doxycycline appear to be effective. …”
    Get full text
    Article
  10. 110

    Targeting epithelial-mesenchymal transition signaling pathways with Dietary Phytocompounds and repurposed drug combinations for overcoming drug resistance in various cancers by A.N.K.V. Sravani, John Thomas

    Published 2025-02-01
    “…This review summarises major EMT-associated pathways and their cross talks with their mechanistic insights and the role of different dietary phytochemicals (curcumin, ginger, fennel, black pepper, and clove) and their natural analogs and also repurposed drugs (metformin, statin, chloroquine, and vitamin D) which are commonly used in regulating EMT in various preclinical studies. …”
    Get full text
    Article
  11. 111

    Simvastatin Does Not Affect Vitamin D Status, but Low Vitamin D Levels Are Associated with Dyslipidemia: Results from a Randomised, Controlled Trial by Lars Rejnmark, Peter Vestergaard, Lene Heickendorff, Leif Mosekilde

    Published 2010-01-01
    “…Objectives. Statin drugs act as inhibitors of the 3-hydroxy-3methylglutaryl coenzyme A (HMG-CoA) reductase enzyme early in the mevalonate pathway, thereby reducing the endogenous cholesterol synthesis. …”
    Get full text
    Article
  12. 112

    Wound repair in rabbits using autologous biomaterials combined with rosuvastatin by Yuri Ferreira Vicentini, Gisele Alborghetti Nai, Rosa Maria Barilli Nogueira, Cecília Laposy Santarém

    Published 2025-02-01
    “…Rosuvastatin (RSV), a lipidlowering statin, exhibits pleiotropic effects that may promote tissue repair, warranting investigation into its use alone or combined with biomaterials for wound healing. …”
    Get full text
    Article
  13. 113

    Towards the Application of Atorvastatin to Intensify Proapoptotic Potential of Conventional Antileukemic Agents In Vitro by Jolanta D. Żołnierczyk, Arleta Kaźmierczuk, Paweł Hikisz, Barbara Cebula-Obrzut, Ewa Wawrzyniak, Jerzy Z. Błoński, Małgorzata Misiewicz, Paweł Robak, Piotr Smolewski, Zofia M. Kiliańska

    Published 2015-01-01
    “…It has been previously revealed that statins used at high concentrations display antileukemic potential towards chronic lymphocytic leukemia (CLL) cells. …”
    Get full text
    Article
  14. 114

    A Rare Cause of Secondary Amyloidosis: Common Variable Immunodeficiency Disease by Ali Kemal Kadiroğlu, Yaşar Yıldırım, Zülfükar Yılmaz, Hasan Kayabaşı, Yahya Avcı, M. Serdar Yıldırım, M. Emin Yılmaz

    Published 2012-01-01
    “…A treatment regimen (an ACE inhibitor and a statin) with monthly administration of intravenous immunoglobulin was started.…”
    Get full text
    Article
  15. 115

    High-Serum Angiopoietin-Like Protein 3 Levels Associated with Cardiovascular Outcome in Patients with Coronary Artery Disease by Ming-Chun Chen, Bang-Gee Hsu, Chung-Jen Lee, Ji-Hung Wang

    Published 2020-01-01
    “…Patients reporting MACEs had lower statin use (P=0.022) and higher serum C-reactive protein (P<0.001) and serum ANGPTL3 (P<0.001) levels than those without MACEs. …”
    Get full text
    Article
  16. 116

    Differences Between Lovastatin and Simvastatin Hydrolysis in Healthy Male and Female Volunteers: Gut Hydrolysis of Lovastatin is Twice that of Simvastatin by Tom B. Vree, Erik Dammers, Ivan Ulc, Stefan Horkovics-Kovats, Miroslav Ryska, IJsbrand Merkx

    Published 2003-01-01
    “…This study was based on the plasma concentration-time curves and the pharmacokinetics of lovastatin and simvastatin with its respective active metabolite statin-β-hydroxy acid obtained from two different bioequivalence studies, each with 18 females and 18 males. …”
    Get full text
    Article
  17. 117

    A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes. by Joyce P Samuel, Susan H Wootton, Travis Holder, Donald Molony

    Published 2022-01-01
    “…<h4>Findings</h4>Twelve randomized trials of the n-of-1 approach were identified in conditions spanning chronic pain, osteoarthritis, chronic irreversible airflow limitation, attention-deficit hyperactivity disorder, hyperlipidemia, atrial fibrillation, statin intolerance, and hypertension. One trial showed a statistically significant benefit in the primary outcome. …”
    Get full text
    Article
  18. 118

    High Serum Adipocyte Fatty Acid Binding Protein Is Associated with Metabolic Syndrome in Patients with Type 2 Diabetes by Jer-Chuan Li, Du-An Wu, Jia-Sian Hou, Yi-Maun Subeq, Hsin-Dean Chen, Bang-Gee Hsu

    Published 2016-01-01
    “…No statistically significant differences in A-FABP levels were found in use of statin, fibrate, or antidiabetic drugs. Multivariate forward stepwise linear regression analysis revealed that body fat mass (P<0.001), logarithmically transformed creatinine (log-creatinine; P<0.001), female DM patients (P<0.001), and logarithmically transformed high sensitive C-reactive protein (log-hs-CRP; P=0.013) were positively correlated, while albumin (P=0.004) and glomerular filtration rate (GFR; P=0.043) were negatively correlated with serum A-FABP levels in type 2 DM patients. …”
    Get full text
    Article
  19. 119

    Safety assessment of rosuvastatin-fenofibrate combination in the treatment of hyperlipidemia based on FDA’s adverse event reporting system database by Qun Li, Wenya Shan, Saiwei Wu

    Published 2025-02-01
    “…In addition to cholesterol reduction, it is imperative to lower triglyceride levels. The combination of statin and fibrate for reducing lipid levels has commonly been applied in clinical therapy. …”
    Get full text
    Article
  20. 120

    Rosuvastatin effects on the HDL proteome in hyperlipidemic patients by Vavlukis Ana, Mladenovska Kristina, Davalieva Katarina, Vavlukis Marija, Dimovski Aleksandar

    Published 2023-09-01
    “…Findings from this study introduce novel insights into the HDL proteome and statin pleiotropism.…”
    Get full text
    Article